Literature DB >> 28368374

Increase of bone marrow macrophages and CD8+ T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation.

N Kawashima1,2, S Terakura2, S Nishiwaki2, D Koyama1,2, Y Ozawa1, M Ito3, K Miyamura1.   

Abstract

Graft failure (GF) remains an obstacle to survival after allogeneic hematopoietic stem cell transplantation. However, differentiating GF from delayed engraftment (DE) can be difficult. Host CD8+ lymphocytes have been reported to mediate graft rejection, but the impact of macrophages on DE or GF is yet to be clarified. Peri-engraftment bone marrow (BM) specimens of 32 adult patients with normal engraftment, DE or GF were retrospectively evaluated to identify the potential associations of CD163+ macrophage and CD8+ lymphocyte infiltration into BM. The macrophage or CD8+ lymphocyte number/total nucleated cell number was defined as the Mac ratio and CD8 ratio, respectively. Both DE and GF groups had significantly higher Mac ratios at day 14 than the normal group (P<0.0001), but no significant difference was observed between the DE and GF groups (P=1.000). The CD8 ratio at day 14 was significantly higher in the GF than in the normal group (P=0.005), whereas the CD8 ratios of the DE and normal groups were similar (P=0.07). A high Mac ratio at day 14 was associated with a risk of DE or subsequent GF. Patients with increased CD8 ratio at day 14 had a further risk of GF. The Mac ratio and the CD8 ratio appear to be well suited for predicting engraftment status.

Entities:  

Mesh:

Year:  2017        PMID: 28368374     DOI: 10.1038/bmt.2017.58

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  50 in total

Review 1.  Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation.

Authors:  S N Wolff
Journal:  Bone Marrow Transplant       Date:  2002-04       Impact factor: 5.483

2.  Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update.

Authors:  Frédéric Baron; Pascale Frère; Etienne Baudoux; Nicole Schaaf-Lafontaine; Georges Fillet; Yves Beguin
Journal:  Haematologica       Date:  2003-07       Impact factor: 9.941

3.  Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysis.

Authors:  S Slot; K Smits; N W C J van de Donk; B I Witte; R Raymakers; J J W M Janssen; A E C Broers; P A W Te Boekhorst; S Zweegman
Journal:  Bone Marrow Transplant       Date:  2015-08-03       Impact factor: 5.483

Review 4.  The role of HLA antibodies in allogeneic SCT: is the 'type-and-screen' strategy necessary not only for blood type but also for HLA?

Authors:  S Yoshihara; K Taniguchi; H Ogawa; H Saji
Journal:  Bone Marrow Transplant       Date:  2012-01-09       Impact factor: 5.483

5.  Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantation.

Authors:  Y Abe; I Choi; K Hara; T Matsushima; J Nishimura; S Inaba; H Nawata; K Muta
Journal:  Bone Marrow Transplant       Date:  2002-05       Impact factor: 5.483

Review 6.  Graft failure after allogeneic hematopoietic cell transplantation.

Authors:  Jonas Mattsson; Olle Ringdén; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

7.  Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes.

Authors:  N A Kernan; N Flomenberg; B Dupont; R J O'Reilly
Journal:  Transplantation       Date:  1987-06       Impact factor: 4.939

8.  Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses.

Authors:  Seitaro Terakura; Eiichi Azuma; Makoto Murata; Tadashi Kumamoto; Masahiro Hirayama; Yoshiko Atsuta; Yoshihisa Kodera; Makoto Yazaki; Tomoki Naoe; Koji Kato
Journal:  Biol Blood Marrow Transplant       Date:  2007-04-30       Impact factor: 5.742

Review 9.  Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis.

Authors:  Sebastian Fn Bode; Kai Lehmberg; Andrea Maul-Pavicic; Thomas Vraetz; Gritta Janka; Udo Zur Stadt; Stephan Ehl
Journal:  Arthritis Res Ther       Date:  2012-06-08       Impact factor: 5.156

10.  Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.

Authors:  W J Murphy; V Kumar; M Bennett
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  4 in total

1.  Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation.

Authors:  Kaito Harada; Shigeo Fuji; Sachiko Seo; Junya Kanda; Toshimitsu Ueki; Fumihiko Kimura; Koji Kato; Naoyuki Uchida; Kazuhiro Ikegame; Makoto Onizuka; Ken-Ichi Matsuoka; Noriko Doki; Toshiro Kawakita; Yasushi Onishi; Shingo Yano; Takahiro Fukuda; Minoko Takanashi; Yoshinobu Kanda; Yoshiko Atsuta; Masao Ogata
Journal:  Bone Marrow Transplant       Date:  2020-02-12       Impact factor: 5.483

2.  Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation.

Authors:  Pietro Merli; Ignazio Caruana; Rita De Vito; Luisa Strocchio; Gerrit Weber; Francesca Del Bufalo; Vanessa Buatois; Paolo Montanari; Maria Giuseppina Cefalo; Angela Pitisci; Mattia Algeri; Federica Galaverna; Concetta Quintarelli; Valentina Cirillo; Daria Pagliara; Walter Ferlin; Maria Ballabio; Cristina De Min; Franco Locatelli
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941

3.  Innate Immune Determinants of Graft-Versus-Host Disease and Bidirectional Immune Tolerance in Allogeneic Transplantation.

Authors:  Anouk A J Hamers; Sunil K Joshi; Asha B Pillai
Journal:  OBM Transplant       Date:  2019-01-31

4.  [Role of imbalance of M1/M2 subsets of bone marrow macrophages in the pathogenesis of immune-mediated aplastic anemia in mice].

Authors:  H Mu; H Jia; Z H Lin; H H Zheng; L Wang; H Liu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.